8-63086020-A-G
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_000370.3(TTPA):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000014 in 1,428,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000370.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151910Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000133 AC: 17AN: 1276686Hom.: 0 Cov.: 31 AF XY: 0.0000143 AC XY: 9AN XY: 628708
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151910Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74214
ClinVar
Submissions by phenotype
not provided Pathogenic:4
This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant is likely to interfere with initiation of protein synthesis. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. -
Initiation codon variant in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9485073, 31970222, 10360777) -
PP1_strong, PP4, PM2, PM3_supporting, PVS1_moderate -
This sequence change affects the initiator methionine of the TTPA mRNA. The next in-frame methionine is located at codon 209. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with ataxia with isolated vitamin E deficiency (PMID: 10360777, 31970222). ClinVar contains an entry for this variant (Variation ID: 189186). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on TTPA function (PMID: 3837850). This variant disrupts the p.Arg59 amino acid residue in TTPA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9463307, 16819822, 17049453, 23599266). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Familial isolated deficiency of vitamin E Pathogenic:2
- -
- -
TTPA-related disorder Pathogenic:1
The TTPA c.2T>C variant is predicted to disrupt the translation initiation site (Start loss). This variant has been reported in the homozygous and compound heterozygous states in individuals with ataxia with vitamin E deficiency (Hoshino et al. 1999. PubMed ID: 10360777; Pradeep et al. 2019. PubMed ID: 31970222). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at